| Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases D Parada Venegas, MK De la Fuente, G Landskron, MJ González, ... Frontiers in immunology 10, 424615, 2019 | 2656 | 2019 |
| Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19) AR Bourgonje, AE Abdulle, W Timens, JL Hillebrands, GJ Navis, ... The Journal of pathology 251 (3), 228-248, 2020 | 1248 | 2020 |
| Proton pump inhibitors affect the gut microbiome F Imhann, MJ Bonder, AV Vila, J Fu, Z Mujagic, L Vork, EF Tigchelaar, ... Gut 65 (5), 740-748, 2016 | 1125 | 2016 |
| Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease F Imhann, AV Vila, MJ Bonder, J Fu, D Gevers, MC Visschedijk, ... Gut 67 (1), 108-119, 2018 | 709 | 2018 |
| Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study ME van der Valk, MJJ Mangen, M Leenders, G Dijkstra, ... Gut 63 (1), 72-79, 2014 | 545 | 2014 |
| Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome A Vich Vila, F Imhann, V Collij, SA Jankipersadsing, T Gurry, Z Mujagic, ... Science translational medicine 10 (472), eaap8914, 2018 | 450 | 2018 |
| Complex host genetics influence the microbiome in inflammatory bowel disease D Knights, MS Silverberg, RK Weersma, D Gevers, G Dijkstra, H Huang, ... Genome medicine 6, 1-11, 2014 | 420 | 2014 |
| Allogeneic bone marrow–derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn’s disease I Molendijk, BA Bonsing, H Roelofs, KCMJ Peeters, MNJM Wasser, ... Gastroenterology 149 (4), 918-927. e6, 2015 | 344 | 2015 |
| Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome LA Bolte, AV Vila, F Imhann, V Collij, R Gacesa, V Peters, C Wijmenga, ... Gut 70 (7), 1287-1298, 2021 | 319 | 2021 |
| Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial MJ de Jong, AE van der Meulen-de, MJ Romberg-Camps, MC Becx, ... The Lancet 390 (10098), 959-968, 2017 | 306 | 2017 |
| Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease G Dijkstra, H Moshage, HM Van Dullemen, A de Jager‐Krikken, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 1998 | 284 | 1998 |
| High frequency of early colorectal cancer in inflammatory bowel disease MWMD Lutgens, FP Vleggaar, MEI Schipper, PCF Stokkers, ... Gut 57 (9), 1246-1251, 2008 | 281 | 2008 |
| Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial CY Ponsioen, EJ de Groof, EJ Eshuis, TJ Gardenbroek, PMM Bossuyt, ... The lancet Gastroenterology & hepatology 2 (11), 785-792, 2017 | 266 | 2017 |
| Detection of infliximab levels and anti‐infliximab antibodies: a comparison of three different assays N Vande Casteele, DJ Buurman, MGG Sturkenboom, JH Kleibeuker, ... Alimentary pharmacology & therapeutics 36 (8), 765-771, 2012 | 233 | 2012 |
| Effects of active and passive smoking on disease course of Crohn's disease and ulcerative colitis F van der Heide, A Dijkstra, RK Weersma, FA Albersnagel, ... Inflammatory bowel diseases 15 (8), 1199-1207, 2009 | 215 | 2009 |
| Molecular prediction of disease risk and severity in a large Dutch Crohn’s disease cohort RK Weersma, PCF Stokkers, AA van Bodegraven, RA van Hogezand, ... Gut 58 (3), 388-395, 2009 | 208 | 2009 |
| Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitisAn unusual case of ascites MC Wapenaar, AJ Monsuur, AA van Bodegraven, RK Weersma, ... Gut 57 (4), 463-467, 2008 | 208 | 2008 |
| Oxidative stress and redox-modulating therapeutics in inflammatory bowel disease AR Bourgonje, M Feelisch, KN Faber, A Pasch, G Dijkstra, H van Goor Trends in molecular medicine 26 (11), 1034-1046, 2020 | 204 | 2020 |
| Role of alkaline phosphatase in colitis in man and rats A Tuin, K Poelstra, A de Jager-Krikken, L Bok, W Raaben, MP Velders, ... Gut 58 (3), 379-387, 2009 | 200 | 2009 |
| Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels H Blokzijl, SV Borght, LIH Bok, L Libbrecht, M Geuken, ... Inflammatory bowel diseases 13 (6), 710-720, 2007 | 187 | 2007 |
Rinse WeersmaMD PhD Professor, Chair Dept of Gastroenterology and Hepatology, University Medical Center GroningenVerified email at umcg.nl
